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VIT d            -           vitamin D
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1INTRODUCTION
Coronary artery disease (CAD),is a leading  cause of mortality and
morbidity world wide and has reached epidemic proportions. Ischemic
heart disease causes 9.4% of total deaths (2.5 million) in less developed
countries and 16.3% (1.3 million) of all deaths in well developed
countries1. The WHO has estimated that in the year 2002 alone, 12.6% of
deaths all over the world were due to coronary artery disease2. The
proportion of these diseases of aging is expected to increase as the world
population gets older.
The Indian scenario is similar. Studies have shown that
cardiovascular diseases cause about 40% of deaths in the urban centers
and  30%  of  deaths  in  rural  centers  in  our  country3.  The   prevalence  of
CVD in the adult population has increased in urban centers from around
2% in 1960 to 6.5% in 1970, 7% in the year 1980, to around 9.7% in
1990 and to a significant 10.5% in the year 2000; while in rural centers, it
has increased to a lesser extent from about 2%  seen in 1970, to 2.5% in
1980, to an estimated 4% in 1990, and finally to a prevalence of 4.5% in
20002.
2Hence prevention of cardiovascular diseases has become extremely
important  and  elucidation  of  CVD  risk  factors  and  assessing  the  risk
profile of an individual patient is paramount.
Apart from the traditional risk factors, vitamin D has recently
emerged as a new risk factor for CVD. It affects multiple homeostatic
mechanisms in the body and is involved with metabolic syndrome,
hypertension, diabetes mellitus, vascular calcification, inflammation,
endothelial dysfunction and atherosclerosis. It is also implicated in the
cause of CAD, heart failure, sudden cardiac death and stroke.
In many of the populations studied, the rate of CVD-related death
is increased at higher latitudes, is more during the winter. This is believed
to  be  due  to  the  adverse  effect  of  reduced  vitamin  D  levels.  Vitamin  D
levels are known to be lower during the winter season and in high
latitudes.
The prevalence of vitamin D deficiency has been estimated to be
around 50% in the aged population throughout the world implying a huge
global expenditure in health services . It has been estimated  that a total of
1 billion of the world’s population  have reduced levels of the hormone
vitamin D .The vitamin D status in Indians is similarly worrying. A study
3conducted in Delhi4 among 1346 healthy subjects of above 50 years
showed that vitamin D deficiency was present in 91.2 %.
As vitamin D deficiency is easily correctable, establishing the
relationship between vitamin D and risk and severity of atherosclerosis is
important.
4AIM OF THE STUDY
1. To evaluate the prevalence of vitamin D in the patients
attending our hospital- both ACS and chronic stable angina
patients.
2. In  ACS  patients,  to  correlate  the  level  of  vitamin  D  on
admission with clinical  endpoints  such as the degree of  LV
dysfunction, killip classification, reinfarction, arrhythmias,
the in hospital mortality, and correlate with  angiographic
lesions such as the number of coronary arteries involved as
well as the severity of lesions as measured by the Gensini
score.
3. In chronic stable angina patients, to correlate the level of
vitamin D with NYHA class & the severity of angiographic
lesions as measured by the Gensini score and the number of
coronary arteries involved.
4. In all patients to correlate the level of Vit D with the Ankle
Brachial Index (ABI) as a measure of peripheral vascular
disease.
5REVIEW OF LITERATURE
It is  estimated that 1 billion people all over the  world are suffering
from some degree of vitamin D deficiency5.  We expose only 5% of our
skin to the sunlight. Sun exposure is further reduced by age, darker
pigmentation, use of sunscreen lotions and increasing latitudes. Thirty
minutes  of  sun  exposure  over  the  arms  and  face,  preferably  between  10
am to 2 pm daily is adequate to avoid Vitamin D deficiency.
 THE INDIAN SCENARIO
India is a tropical country where summer is the predominant
season. Despite our climate vitamin D deficiency is rampant in our
country. The prevalence of vitamin D deficiency in India has been
estimated to be 50-90% according to earlier studies6.
Harinarayan et al studied the effects of 25(OH)D on BMD and
shown that Vit D deficiency is present in  76%  of women in reproductive
age group and 70% in postmenopausal women6.
It is a common problem in India despite our sun exposure due to
multiple factors such as altered food habits, a high fiber diet which
contains phosphates and phytates which  lead to depletion of vit D stores
and increase our calcium requirement7, genetic factors such as elevated
625(OH)D-24- hydroxylase8, and in urban Indians, the number of hours
spent indoor has increased plus the increased pollution in urban centers
can prevent the ultraviolet rays from adequately synthesizing vit D in the
skin9,repeated pregnancies in already vit D deficient patients   aggravate
Vit D deficiency both  in  the mother and the  developing fetus.
 VITAMIN D PHYSIOLOGY
Vitamin D is a steroid hormone which is obtained through food
sources or synthesized in the body. It is an integral part of the “vitamin
D-Parathyroid hormone- Calcium” endocrine axis. It is necessary for the
optimal absorption of dietary calcium and phosphate and adequate intake
of calcium and vitamin D is necessary to maintain the peak bone mass.
The “D” in the vitamin  represents either D2 or D3.Vit D2 is called
“ergocalciferol” and D3 is called “cholecalciferol”. 1,25(OH)2D3  is
known as calcitriol. D3 is the most natural form and the type synthesized
in humans and found in most healthy fish. D3 is less toxic and more
potent form of the vitamin. For fortification purposes vitamin D2 is
manufactured by ultraviolet irradiation of ergosterol obtained from yeast,
and vitamin D3 is obtained by ultraviolet irradiation of 7-
dehydrocholesterol obtained from lanolin.
7DIETARY SOURCES OF VITAMIN D
 Vitamin D is present in very few foods. Good sources being cod liver oil
and  sardines, mackerel and salmon.
     Food sources of vitamin D
Food types IU per serving
Cod liver oil ,1 table spoon 1,360
Swordfish, 3 ounces (85 grams) 566
Salmon, 3 ounces (85 grams) 447
Orange juice fortified with vit D, 1 cup 137
Fortified milk, 1 cup 115-124
Liver,3 ounces  (85 grams) 42
Egg 1 large 41
Cheese 6
SYNTHESIS OF VITAMIN D
Vitamin D is synthesized primarily from the compound
7-dehydrocholesterol (provitamin D3 ) which is present  in our skin.
When skin is exposed to sunlight the 7-dehydrocholesterol in the skin
absorbs UV-B rays of wavelength 290-315 nm 10 to form the 9,10-
secosterol,known as previtamin D3.This previtamin D3  forms the stable
Vitamin D3  by a process known as thermal isomerization.
8For the metabolic activation of vitamin D to take place, first
hydroxylation occurs primarily in the liver. CYP2R1 is the presumed
hepatic cytochrome which  25-hydroxylates  both forms of vitamin D-
D3 and  D2.This cytochrome is  present    predominantly in the liver  and
testis11.  It  has  been  shown  that    2R1  gene  mutations   are  present   in
patients with low 25-(OH)D levels and rickets12.Hence  CYP2R1 seems
to be the critical in the metabolism of the hormone vitamin D. To assess
the vitamin D status ,the  commonly used indicator which is measured is
plasma 25(OH)D levels13.
The next step in vitamin D formation is the conversion to[1,25-
(OH)2D]. This occurs mainly in the kidney. The renal enzyme 25(OH)D-
1-?-hydroxylase mediates the conversion to the activated form of vitamin
D- the hormone 1,25(OH)D. 1-? hydroxylase is found in the
chromosome 12, the site of defect in (type I vitamin D-dependent rickets
or VDDR-I)14.
But other cells produce vitamin D in conditions such as pregnancy,
CKD, sarcoidosis, TB, rheumatoid arthritis  and granulomatous disorders.
This 1,25 (OH)2D  produced outside the kidneys serves  a paracrine
function. The 1-? hydroxylase enzyme is also  found in prostate, breast,
colon, monocytes, lungs, pancreas,  and in parathyroid  cells15.
9Dietary calcium regulates 1-? hydroxylase directly through
changes in serum calcium and indirectly by changing parathormone
levels16. Calcium directly suppresses 1?-hydroxylase activity and  mRNA
in  human cell lines from renal proximal tubules17. Parathormone also
directly regulates the 1-? hydroxylase enzyme through changes in
cAMP18.
Restricting dietary phosphate increases renal 1-? hydroxylase19
activity independently of changes in PTH20  and calcium21. The effect of
dietary phosphate on 1-? hydroxylase are mediated by phosphaturic
factors or phosphatonins, and through ?broblast growth factor 23 and
matrix extracellular phosphoglycoprotein (MEPE).
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MECHANISMS OF  VITAMIN D TRANSPORT
Vitamin D is a fat soluble  compound with poor water solubility.
Hence it has to be bound to plasma proteins for transport. The most
important carrier in the plasma  is vitamin D binding protein (DBP). This
binds the vitamin D compounds  with high af?nity in the order of
25(OH)D =24,25(OH)2D > 1,25(OH)2D > vitamin D22.  >99%  of  the
11
circulating vitamin D compounds in the plasma are protein bound, mostly
to DBP and to a lesser extent to albumin and lipoproteins. DBP-bound
vitamin D metabolites are less prone for metabolism by liver hence they
have a longer half life. Only the unbound metabolites can enter the cells
to produce their biologic action. Hence DBP prevents vitamin D
toxicity.23. DBP levels are elevated during pregnancy and estrogen
therapy and reduced with liver disease and nephritic syndrome. But the
free vitamin D levels do not change when DBP levels alter.
Vitamin D Metabolism
Vitamin D is inactivated inside the cells by vitamin D 24-
hydroxylase, which catalyzes   oxidation, side chain cleavage followed by
inactivation. 24-Hydroxylase activity is increased by phosphate19,24  and
reduced by PTH25.
MECHANISM OF ACTION
It binds to a high-affinity receptor which functions as a
transcription factor. This vitamin D receptor (VDR) belongs to the steroid
receptor superfamily. It causes gene transcription by ligand binding
followed by heterodimerization with a retinoid X receptor, then binds to
vitamin D response elements, and recruits other nuclear proteins. It may
12
also act additionally through non–VDR pathways or nongenomic VDR-
mediated pathways26,27.
Many tissues possess 1-?-hydroxylase activity. The significance of
these paracrine mechanisms of vitamin D production is not clear. This
paracrine production may be involved in multiple physiologic functions,
such as of cytokines regulation,  the renin-angiotensin system, vascular
function, immuno modulation, cellular growth as well as  differentiation
and inflammatory and/or fibrotic pathways28-34.
RECOMMENDED  DAILY  INTAKE
Institute of Medicine has recommended the following as adequate daily
intake35
? for children and in adults up to 50 years   -- 200 IU
? for adults between 51 to 70 years   -- 400 IU
? for adults above 71 years – 600 IU
But in the absence of enough exposure to sunlight, the  requirement
for  children and in adults rises to approximately 800 to 1000 IU per
day36-41.
One method for  vitamin D supplementation to maintain adequate
levels is to administer patients one  50,000-IU capsule of  D2 given  once
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a week for total of 8 weeks, then 50,000 IU of  vitamin D2 every 2 to 4
weeks37,42,43.Other strategies being to give 1000 IU of vitamin D3 every
day or to give 3000 IU of vitamin D2 daily37,42,44,45.
Association with disease
The traditional diseases due to vitamin D deficiency such as rickets
and osteomalacia are well known. The benefit of vitamin D for
prevention of fractures has also been noted46. The antifracture effect was
dose dependant. Higher doses reduced fractures by 20% in patients >65
years.
The lesser known effects of vitamin D involves the two great
killers of the world today such as cardiovascular disease and cancers.
Epidemiologic studies have shown that there is an association
between moderate (<15 ng/mL) and severe (<10 ng/mL) levels of vitamin
D  with increased CV risk47.
Multiple studies have shown that a 30 -50% higher cardiovascular
morbidity and mortality is produced when the exposure to the sun is
reduced48-52.
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Vitamin D deficiency is associated with ischemic heart disease ,
myocardial infarction , hypertension, calcific aortic stenosis  and even
sudden cardiac death.
Low 25-OH D levels are seen in heart failure53 and in stroke54.
vitamin D deficiency has also been found to be associated with  metabolic
syndrome55, glucose intolerance56  and in obesity56. Heart failure patients
have 34% lower levels of vitamin D when compared to healthy
participants53.
Population based cross sectional study from Scandinavia has
shown that serum levels of vitamin D were inversely correlated with
blood pressure, triglycerides, and triglyceride removal in an IV fat
tolerance test57. Serum levels of  25-OH D vitamin D  also correlate with
fasting insulin, insulin sensitivity, and lipoprotein lipase activity in
skeletal muscle and adipose tissue57.  These  findings  suggest  the  role  of
vitamin D in the metabolic syndrome.
Many epidemiologic studies have shown an association between
vitamin D deficiency and cardiovascular  mortality. Dobnig et al58  in
2008 reported a single center study in patients referred for angiogram
with a 7.7 year follow up. It showed that lower two quartiles of serum
vitamin D had higher all cause and cardiovascular  mortality.
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Pilz et al59 in 2008 reported a single center study on 3316 patients
referred for angiogram and showed that reduced vitamin D levels were
associated with increased strokes both fatal/nonfatal. Wang et al47 in 2008
reported on a total of 1739 patients with 5.4 years of  follow up which
showed  that  low  serum  vit  D  levels  (<15  ng/ml)   was  associated  with
increased CVD events. Melamed et al60 in 2008 reported on 13,311
patients from the Third National Health and Nutrition Examination
Survey with 8.7 year follow up showing that patients with the lowest
quartile of serum vit D (<17.8 ng/ml) had higher all-cause mortality than
those with the highest quartile.
A prospective nonrandomized study conducted among 1739
patients  in  the   Framingham Offspring  Study   showed that   those   with
vit D levels (<37.5 nmol/l) had a hazard ratio of 1.62 for myocardial
infarction,  and heart failure compared with those with vit D levels of at
least 37.5 nmol/l47.The cumulative probability of first cardiac events were
substantially higher in hypertensives who were also vitamin D deficient.
In the Health Professionals Follow-up Study , men with low vit D
levels (<37.5 nmol/l) had a RR of  2.09  of myocardial infarction  when
compared with men with suf?cient  vit D levels61.
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Reduced  25-OH D levels  are also related with higher incidences
of cancer62 and immune dysfunction28. The LURIC study of 3316 patients
that low vitamin D levels independently predicted fatal stroke. Stroke
prevention by vitamin D  supplementation is an intriguing prospect63.
VITAMIN D AND THE HEART
The hormone acts on myriad cells involved in cardiovascular
homeostasis such as cardiomyocytes, vascular smooth muscle cells and
the endothelium. Vitamin D  is involved in the development of known
cardiac risk factors such as insulin resistance, HT, obesity  and metabolic
syndrome.
MECHANISMS OF CVD PROTECTION
The exact mechanism by which vitamin D exerts its protective role
on the cardiovascular system is yet to be fully elucidated. Vitamin D is a
potent hormone which suppresses the renin angiotensin system and in
regulation of the  blood pressure. It also inhibits thrombosis and arterial
calcification. Vitamin D deficiency also increases parathormone levels
which have adverse effects on the cardiovascular system.
It reduces inflammation by increasing anti-inflammatory
messengers  such  as  IL-10.  It  can  reduce  lymphocyte  proliferation  and
17
cytokine production. Preclinical and clinical studies have shown a
positive effects of vitamin D on endothelial regeneration,  smooth muscle
cell growth, fibrinolysis, and  thrombogenicity64.
Vitamin D receptors (VDR) are expressed in cardiomyocytes.
Studies in rats have shown that vitamin D is protective against
myocardial hypertrophy and   dysfunction and suppresses RAS and genes
involved in cardiac hypertrophy 65-69.
Vitamin D therapy reduces the  QTc dispersion, which is a known
risk factor for sudden death70,71.
EXPERIMENTAL DATA  IN CARDIOMYOCYTES
Vitamin D affects the growth and proliferation of murine
cardiomyocytes. Calcitriol treatment increases the expression  of cardiac
myotrophin  and  decreases  the  expression  of  ANP  -   a  risk  marker  with
inverse relation  to cardiac function. Giving vit D also increases the
expression of VDR and causes nuclear localization in these cells65.
Cardiomyocytes obtained from VDR knockout mice show
accelerated contraction and relaxation  when compared with wild type
mice, and vit D directly affected contractility in the wild type but not in
18
the knockout  cells66.  Hence  we  see  that  1,25(OH)D   is  an  important
hormone which modulates   heart cell structure and function.
VDR knockout mice also show hypertrophy of  cardiac myofibrils
and have underexpression of  tissue inhibitors of metalloproteinases72.
Matrix metalloproteinases (MMPs) are enzymes involved in the
myocardial remodelling process. They cause destabilization of   atheroma
plaques leading  to  rupture followed by thrombosis. MMPs contribute to
progressive ventricular remodelling and dilation, leading to heart failure.
In rats who were hypertensive and developed heart failure, 1,25(OH)D
treatment caused  lower heart weights and   collagen levels and less LV
diameter  when compared with untreated rats73.
ROLE OF VITAMIN D IN HYPERTENSION
Hypertension is a well known independent risk factor for CVD.
Experimental  effects on the vasculature
Vitamin D has a protective role on the vasculature. These
beneficial effects include down regulation of MMPs and proin?ammatory
cytokines such as  (IL)-1, IL-6, and (TNF)-?74,75.  There  is also increase
in  the anti-in?ammatory cytokine IL-10 along with  vascular calci?cation
inhibitors such as matrix Gla protein (MGP), are also increased along
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with  type IV collagen present in vascular SMCs. Vitamin D reduces the
effect of advanced glycation end products (AGEs) which have a
deleterious effect on the endothelial cells.
Mechanism for development of hypertension in vitamin D
de?ciency  is  due  to  the  activation  of  the  RAS.  Synthesis  of  renin   is
increased many times  in the renal  cells of vitamin D receptor knockout
mice76,77 . VDR-null mice have been shown to have three times higher
renin mRNA  and the angiotensin II levels which were more than 2.5
times greater than in wild-type mice.
The   data  on  12  644  patients  from  the  third  National  Health  and
Nutrition Examination Survey (NHANES) showed a modest but still
signi?cant inverse correlation between serum vitamin D levels and BP
after adjustment for other risk factors78.
ROLE OF VITAMIN D IN LVH
Hypertrophy of the left ventricle (LVH) is a very strong  risk factor
for cardiovascular mortality. Two  clinical trials on hemodialysis patients
show  that  treatment  with   vitamin  D   may  lead  to   LVH  regression,
suggesting a possible cardioprotective action79,80.  Vitamin  D  affects  the
myocardium directly and regulates myocardial hypertrophy, as cardiac
hypertrophy is observed in the hearts of VDR knockout mice81.
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Bodyak  et  al82 demonstrated that paricalcitol reduced sodium-
induced abnormalities of LV in HT rats which were Dahl salt-sensitive.
VITAMIN D AND HEART FAILURE
A small  study75 which included 43 males and 17 females with an
ejection fraction of <40%  showed that  a longer 6-min walk distance
correlated with higher 25(OH)D levels. Very low serum 1,25-
dihydroxyvitamin D  levels (<37.5 pmol/l) have  been demonstrated in
end-stage heart failure patients74.
Vitamin D and ECHO abnormalities
Studies have implicated an association between vitamin D
deficiency and mitral ring calcification83. Calcific aortic stenosis is
associated with vitamin D receptor polymorphism84.
VITAMIN D AND CORONARY ARTERY DISEASE
The vitamin D axis affects inflammation, proliferation of  vascular
smooth muscle cells  and vascular calcification along with blood
pressure85. All these risk factors affect the development and progression
coronary artery disease (CAD). But the data which directly link vitamin
D levels to MI are only sparsely available.
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A study conducted in Denmark on 128 patients with CAD versus
409 controls shows that vitamin D levels were significantly lower in
patients with angina86. Another study done in New Zealand87 on 179
patients  with  MI  showed  that  MI  patients  lower  mean  25(OH)D  levels
and that relative risk (RR) of MI decreased across the increasing quartiles
of vtamin D (<10 ng/mL the  RR was 1 , and in those with 10-13 ng/mL:
RR was 0.56 and in those patients with 13.1-16.8 ng/mL: RR was 0.33
and in patients  >16.8 ng/mL: RR was 0.30.
One  of  the  mechanisms  by  which  vitamin  D  affects  MI  risk  is
through its effect on calcification. Calcification is commonly seen in
atherosclerotic lesions and nearly all of the angiographically significant
lesions are calcified88. Coronary artery calcification is associated with
higher risk of MI89 and worse 5 year survival90. Levels of 1,25-
dihydroxyvitamin D are  inversely associated with vascular calcification
seen in CAD patients91.
Low vit D is associated with greater inflammation (eg, increased
CRP and IL 6 levels and lower IL 10 levels), which could possibly
predispose to the increased risk of  MI92-95.
The  levels  of  vitamin  D  varies  among  the  subgroups  in  CAD  ie,
among chronic stable angina, unstable angina and acute MI. In an ACC
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moderated poster contribution in ACC 12, a study from Utah96 analyzed
the distribution of vitamin D among the CAD subgroups at presentation.
In stable angina patients  38.1%  had vitamin D levels of <15 ng/ml and
36.5% had value between16-30 ng/ml and only 37.8% of the patients had
a  normal  value  of  >30ng/ml.  Unstable  angina  patients   had   values  of
<15ng/ml in  35.0%,  and 40.7%  of patients had a value of 16-30 ng/ml
and 44.2% had a normal value of >30 ng/ml. Among MI patients the
values were:  26.9% patients had <15ng/ml, 22.7% of patients had a value
of 16-30 ng/ml and 18.0% had a normal value of >30 ng/ml. This study
concluded that Vit D deficiency is seen to be prevalent among  CAD
patients  regardless  of  their  mode  of  presentation  but  severe   Vit  D
deficiency is  most prevalent in those with chronic (stable) angina  and
best predicts risk of future cardiovascular events.
Vitamin D levels and angiographic severity of lesions
Data  on  the   severity  of  vitamin  D  deficiency  and  the  extent  of
angiographic severity of  CAD are limited.
In the (LURIC) study , although lower levels of the hormone were
associated with heart failure, all-cause and CV mortality, the relationship
between vitamin D levels and angiographic severity of CAD was not
reported58,59.
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Lee et al97 reported a higher  prevalence of vitamin D deficiency in
MI patients who underwent angiograms but the correlation of vitamin D
levels with angiographic CAD was not mentioned.
Studies of vitamin D levels in Indian patients with angiographical
CAD have reported conflicting results. Even though Shanker et al98
showed that patients in the lower vitamin D quartile had  higher risk for
CAD, they did not find an association with severity of CAD.
Rajasree et al99 reported that the risk of CAD paradoxically
increased in  patients with vit D levels >89 ng/mL when compared to
those with lower levels.
Among Indian patients who undergo coronary angiograms, 80%
are vitamin D deficient, while another 13% had insufficiency of vitamin
D levels. Only 7% of these patients had normal vitamin D levels100. This
reflects the high prevalence of vitamin D deficiency in the Indian
population in general.
In a study of 3,413  patients with clinically indicated coronary
angiography,  there was shown to be  no significant association between
their vitamin D levels and the assessed angiographic severity of CAD101.
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In a Turkish study102 reported in 2012, low vit D levels were
associated with the angiographic severity of lesions as measured by the
Gensini score. The Gensini score was negatively associated with serum
vitamin D levels (r = -0.416, P < 0.001).
An Italian study103 on differential protein expression in MI patients
showed that lower  levels of vitamin D binding protein  in MI patients
correlated  statistically with the number of involved coronary arteries.
 The down regulation of  vitamin D binding protein  is most  marked in
patients with  multivessel disease.
Vitamin D supplementation and cardiovascular risk
The effects of vitamin D supplementation are multiple.
Supplementation improves bone strength, and may reduce vascular
calcification. Vitamin D has anti-inflammatory properties104 and
supplementation lowered C-reactive protein in 2 small clinical trials105,106.
The current recommended daily allowance is 200 IU for adults
aged from 20-50 years, 400 IU in adults of 51-69 years age, and 600 IU
in patients  >70 years. But the daily requirement in the older adult which
is needed to maximally suppress the parathormone levels is 800 IU per
day107.
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Schleithoff et al reported that heart failure patients who were
treated with 2000 IU/d of VitaminD had reduced serum TNF levels and
increased interleukin-10 (anti-inflammatory cytokine) levels108.
Witte et al109  used smaller dose of vitamin D  of  400 IU/day but
were unable to show a reduction in cytokine levels measured in heart
failure. Hence treatment with vitamin D at a dose which is higher than the
current recommended daily intake may be needed to reduce the
cardiovascular risk.
But those who benefit from supplementation may be those at high
risk for developing a CVD event or those with reduced  vitamin D levels.
Obese individuals have lower levels of  vitamin D and improving the
hormone levels in these patients may be more beneficial than in patients
normal vitamin D levels.
Pfeifer et al110, have  noticed a reduction in BP and  the heart rate
after the administration of 800 IU of vit D plus 1200 mg of calcium when
compared with giving only1200 mg/d calcium  to elderly women,
suggesting  that  reduced  intake  of  both  vit  D  and  calcium   play  a
contributory role in the development and progression of hypertension and
CVD.
26
Lower mortality has  been observed in a vitamin D intervention
trial conducted in Britain111 . In this study the  vitamin D group received
2500?g  of vitamin D every 4 months over the course of  5 years  which
is equivalent to 21?g vitamin D per day. Even if statistical signi?cance
was not achieved , yet incidence rate ratios were noted to be always close
to 1.0, but the  mortality rate ratios were always lower, suggesting that the
protective effect of vitamin D on cardiovascular and cancer mortality is
more effective than its effect on disease incidence.
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MATERIALS AND METHODS
PATIENTS
This study was conducted from March 2012 to February 2013. The
study population includes patients admitted to our ICCU with Acute
Coronary Syndrome (ACS) and patients with effort angina (EA)who
underwent coronary angiogram. The diagnoses were confirmed by
experienced cardiologists and angiograms were performed as indicated by
the patient’s clinical profile and presentation according to established
guidelines.
Inclusion criteria
? Age from 18 – 75 years
? Acute coronary syndrome patients being admitted  to our ICCU
? Chronic stable angina patients undergoing angiogram
Exclusion criteria
? chronic kidney disease patients
? patients with known diseases involving the Parathormone –
vit D axis such as hyper/hypo parathyroidism, hyper/
hypovitaminosis D
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? patients who are on calcium and vitamin D /parathormone
supplementation.
Data collection technique and tools
Ethical issues:
As this  study  involves  the  taking  of   blood  investigations,  and  an
invasive diagnostic procedure such as coronary angiogram, all patients
and  their  relatives  were  explained   the  study  design  at  the  time  of
enrollment.
Informed consent was obtained from all patients at the time of
admission (a copy is  enclosed).
The following demographic and clinical data were  obtained as
soon as the patient was admitted and enrolled.
A  proforma  (a  copy  enclosed)  for  each  patient  was  filled  which
included
Detailed clinical history :
? Age of the patient
? Symptom history
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? A complete risk factor profile (including diabetes,
hypertension, dyslipidemia, smoking, family history, prior
history of CAD) .
? physical examination
o Including the pulse rate, blood pressure, cardiac &
respiratory system clinical examination,
o Anthropometric measurements such as the height,
weight,body mass index,
Investigations
? A 12 lead electrocardiogram was obtained. ECG using right
sided leads or posterior leads was taken if necessary.
? Echocardiogram was performed at time of admission and
prior to discharge.
? Complete blood investigations including blood counts, blood
sugar, urea and creatinine , liver function test, HBsAg, HCV,
and HIV were taken at admission.
? Blood levels of vitamin D were assessed from samples taken
at time of admission
? e GFR was calculated by the Cockroft Gault formula
? ABI was calculated at time of admission
30
? Chest x ray PA view
? Coronary angiogram performed during index hospitalization
or as a delayed strategy as may be warranted.
Echocardiography was performed using Aloka model no: IPC -
1530 by experienced cardiologists.
SAMPLE COLLECTION
Blood samples were obtained on admission. 2 ml of non
heparinised blood was collected under strict aseptic precautions from the
antecubital vein and refrigerated. This sample was sent to the laboratory
where it was centrifuged to separate the serum. The method of assay is
the Chemiluminescence immunoassay (CLIA) using a fully automated
Diasorin system.
Vitamin D deficiency (<30ng/ml) is further graded  according to
serum 25-OH D levels as deficient, insufficient, hypovitaminosis.
Range of Vitamin D levels112-114
25-OH D Level ng/mL
Deficient <10
Insufficient 10-20
Hypovitaminosis 20-30
Adequate 30-100
Toxic >100/140
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A vitamin D level of more than 30 ng /ml  indicates adequate levels
of vitamin D115. The vitamin D status is best reflected by  serum 25-OH D
levels since this compound has a half life lasting several weeks. The
biologically active form which is 1,25-(OH)2- vitamin D is not routinely
measured  as this has a short half life lasting for only a  few hours. The
vitamin D levels are expressed in two units, either in International Units
(IU) or nanograms(ng) /ml. One microgram is equivalent to 40 IU.
Coronary angiogram was done at  a  median of  1 day (range 0 to 5
days) after admission using the Siemens 2000. The studies were
performed and reviewed by a team of  cardiologists with advanced
training in the catheterization laboratory.
The Gensini score116 was used to calculate the severity of
angiographic lesions and verified by a team of experts. This score assigns
heavier weight to more severe luminal narrowings and also gives weight
to the segment of coronary artery involved according to vessel size and
importance; segments that serve larger regions are more heavily
weighted.
A 25% diameter reduction is given a score of 1. Likewise diameter
reduction is scored as following;  50% reduction  as 2; a 75% reduction as
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4; a 90% reduction as 8;a  99% reduction is scored as 16 and 100% cut
off is scored as 32. This score is multiplied by the weight given to
coronary segments such as Left main 5; prox LAD is given 2.5; mid LAD
1.5; distal LAD 1;the first diagonal is given 1 and second diagonal is
given 0.5;  prox LCX is given 2.5 if nondominant and 3.5  if dominant;
distal LCX is given 1 (nondominant) and 2 (dominant). OM s 1;PLB
0.5;PDA 1;RCA  1each  for prox ,mid,and distal. The diameter reduction
score is multiplied by the coronary segment score for each lesion. The
total gives the Gensini score for the patient.
Analysis of the Results
The  data collected during the study period was compiled, analyzed
and interpreted according to the  objectives and parameters that had been
decided.
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Statistical Analysis
All  statistical  analysis  were  done  with  SPSS  version  16.0  for
windows. The data are expressed as Mean ± SD for quantitative data. The
qualitative data are expressed as frequency and percentage. The
differences between multiple groups were analyzed using  the student t
test and Annova. The descriptive  data were used for chi-square analysis.
The probability value less than 0.05 was considered significant.
Pearson chi square test was used to compare vitamin D levels with all
the parameters including the angiographic distribution of lesions and
severity as per the Gensini score.
34
RESULTS
          Data Analysis
Table 1: vitamin D x Sex
Vitamin
D ng/ml Male Female Total P Value
>30 12 3 15 Chi-square=1.08
Df=3
p=0.80
(Not significant)
20-30 27 7 34
10-20 35 5 40
<10 16 3 19
TOTAL 90 18 108
Mean 18.93±8.39 20.50±8.66 19.00±8.42 t=0.83 df=106 p=0.41
Not Significant
Chi-square=1.08 with 3 degrees of freedom. The association
between vitamin D levels and the sex of the patient was not significant
(p=0.80).
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Table 2: vitamin D x Age
Base line Characteristics:
Age (Mean ± SD)
Male 52.09 ± 10.29
Female 54.22 ±  9.42
Total 52.41 ±  10.14
                        t = 0.81        df=106       p=0.42  Not significant
vitamin
D
ng/ml
<40yrs 40-60yr >60yrs Total P Value
>30 2 10 3 15 Chi-square
2.14
Df= 6
p=0.91
Not
Significant
20-30 7 20 7 34
10-20 4 26 10 40
<10 2 13 4 19
Total 15 69 24 108
Mean 20.79±7.98 18.68±8.70 18.81±8.06 19.04±8.42 F=0.39
df=2,105
p=0.68
Not
Significant
Chi-square=2.14 with 6 degrees of freedom. The association
between vitamin D levels and the age of the patient was not significant
(p=0.91)
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Table 3: vitamin D x Diagnosis
vitamin
D ng/ml
ACS EA Other
indications
Total P Value
>30 10 3 2   15 Chi
square=13.37
Df=6
P=0.04
Significant
20-30 18 15 1 34
10-20 27 13 0 40
<10 16 3 0 19
Total 71 34 3 108
Chi-square=13.37 with 6 degrees of freedom. The association between
vitamin  D  levels  and  the  presentation  of  the  patient  was significant
(p=0.04)
Table 4: vitamin D x Smoking
vitamin
D ng/ml Smoker
Non
smoker Total P Value
>30 5 10 15 Chi
square=1.55
Df=3
P=0.67
Not
Significant
20-30 13 21 34
10-20 17 23 40
<10 10 9 19
Total 45 63 108
Mean 19.61±8.46 18.11±8.38 t=0.93 df=106
p=0.36 Not
Significant
Chi-square=1.55 with 3 degrees of freedom. The association
between vitamin D levels and  smoking was not significant (p=0.67).
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Table 5: vitamin D x SHT
vitamin
D ng/ml Hypertensive
Not known
Hypertensive Total P Value
>30 3 12 15 Chi
square=4.23
Df=3
P=0.24
Not
Significant
20-30 14 20 34
10-20 20 20 40
<10 9 10 19
Total 46 62 108
Mean 17.32±7.89 20.25±8.65 t=1.81
df=106
p=0.07 Not
Significant
Chi-square=4.23 with 3 degrees of freedom. The association
between vitamin D levels and  HT was not significant (p=0.24).
Table 6: vitamin D x Diabetes
vitamin
D ng/ml Diabetics
Non
Diabetics Total P Value
>30 5 10 15 Chisqure=3.14
Df=3
P=0.37
Not significant
20-30 11 21 34
10-20 19 23 40
<10 10 9 19
Total 63 45 108
Mean 19.78±8.56 17.64±8.13 t=1.43 df=106
p=0.16 Not
Significant
Chi-square=3.14 with 3 degrees of freedom. The association
between vitamin D levels and  DM was not significant (p=0.37)
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Table 7: vitamin D x Dyslipidemia
vitamin D
ng/ml Present Absent Total P Value
>30 6 9 15 Chi
square=5.58
Df=3
P=0.13
Not
Significant
20-30 12 22 34
10-20 24 16 40
<10 11 8 19
Total 53 55 108
Mean 17.67±7.77 20.29±8.88 t=1.63 df=106
p=0.11 Not
Significant
Chi-square=5.58 with 3 degrees of freedom. The association
between vitamin D levels and  dyslipidemia was not significant (p=0.13)
Table 8: vitamin D x Obesity
vitamin D
ng/ml Present Absent Total P Value
>30 2 13 15 Chi square
=7.33
Df=3
P=0.06
Not
Significant
20-30 0 34 34
10-20 8 32 40
<10 3 16 19
Total 13 95 108
Mean 15.75±9.11 19.45±8.27 t=1.49
df=106
p=0.14 Not
Significant
Chi-square=7.33 with 3 degrees of freedom. The association
between vitamin D levels and  obesity was not significant (p=0.06)
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Table 9: vitamin D x NYHA Classification
vitamin D
ng/ml 0 II III IV Total P Value
>30 12 3 0 - 15 Chi
square=7.61
Df=6
P=0.27
Not
significant
20-30 21 9 4 - 34
10-20 25 6 9 - 40
<10 15 2 2 - 19
Total 73 20 15 108
Chi-square=7.61 with 6 degrees of freedom. The association
between vitamin D levels and  the NYHA functional class was not
significant (p=0.27)
Table 10: vitamin D x Killip Classification
vitamin
D
ng/ml
1 2 3 4 Total P Value
>30 6 0 0 1 7 Chi square=10.21
Df=9
P=0.33
Not  Significant
20-30 11 3 1 0 15
10-20 12 3 4 0 19
<10 8 1 3 2 14
Total 37 7 8 3 55
Chi-square=10.21 with 9 degrees of freedom. The association
between vitamin D levels and  Killip Classification was not significant
(p=0.33).
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Table 11: vitamin D x Inotropic Support
vitamin D
ng/ml YES NO Total P Value
>30 1 14 15 Chisquare=9.54
Df=3
P=0.02
significant
20-30 1 23 34
10-20 6 34 40
<10 6 13 19
Total 14 94 108
Chi-square=9.54  with 3 degrees of freedom. The association
between vitamin D levels and Inotropic Support  was significant
(p=0.02)
Table 12: vitamin D x Death
vitamin D
ng/ml YES NO Total P Value
>30 1 14 15 Chisquare=11.00
Df=3
P=0.01
significant
20-30 0 34 34
10-20 1 40 40
<10 3 16 19
Total 4 104 108
Chi-square=11  with 3 degrees of freedom. The association
between vitamin D levels and death  was significant (p=0.01).
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Table 13: vitamin D x Re MI
vitamin D
ng/ml YES NO Total P Value
>30 0 15 15 Chisquare=10.73
Df=3
P=0.01
significant
20-30 1 33 34
10-20 1 39 40
<10 4 15 19
Total 6 102 108
Chi-square=10.73  with 3 degrees of freedom. The association
between vitamin D levels Re infarction  was significant (p=0.01).
Table 14: vitamin D x Arrhythmia
vitamin D
ng/ml YES NO Total P Value
>30 1 14 15 Chi
square=22.32
Df=3
P=0.000
significant
20-30 3 31 34
10-20 11 29 40
<10 12 07 19
Total 27 81 108
Chi-square=22.32  with 3 degrees of freedom. The association
between vitamin D levels and arrythmia  was significant (p=0.000).
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Table 15: vitamin D x Left Ventricular Dysfunction
vitamin D
ng/ml
YES NO Total P Value
>30 8 7 15 Chi
square=4.54
Df=3
P=0.21
Not
significant
20-30 20 14 34
10-20 26 14 40
<10 16 3 19
Total 70 38 108
Chi-square=4.54  with 3 degrees of freedom. The association
between vitamin D levels and LV dysfunction was  not significant
(p=0.21)
Table 16: vitamin D x MR
vitamin
D
ng/ml
Mild moderate trivial none Total P Value
>30 3 1 11 15 Chi
square=10.07
Df=6
P=0.12
Not
significant
20-30 13 1 20 34
10-20 22 3 15 40
<10 12 1 6 19
Total 50 6 52 108
Chi-square=10.07  with 6 degrees of freedom. The association
between vitamin D levels and Mitral regurgitation  was not significant
(p=0.12).
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Table 17: vitamin D x aortic sclerosis
vitamin D
ng/ml
YES NO Total P Value
>30 4 11 15 Chi
saqure=4.81
Df=3
P=0.18
Not
significant
20-30 9 25 34
10-20 17 23 40
<10 10 09 19
Total 40 68 108
Chi-square=4.81  with 3 degrees of freedom. The association
between vitamin D levels and aortic sclerosis  was not significant
(p=0.18).
Table 18: vitamin D x Diastolic Dysfunction
vitamin
D ng/ml Normal I II III Total P Value
>30 6 8 0 1 15 Chi
square=30.31
Df=9
P=0.000
significant
20-30 5 25 2 2 34
10-20 2 29 2 7 40
<10 0 11 6 2 19
Total 13 73 10 12 108
Chi-square=30.31with 9 degrees of freedom. The association
between vitamin D levels diastolic dysfunction was significant (p=0.000).
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Table 19: vitamin D x normal coronaries
vitamin D
ng/ml YES NO Total P Value
>30 3 12 15 Chi
square=9.40
Df=3
P=0.02
significant
20-30 8 26 34
10-20 1 39 40
<10 1 18 19
Total 13 95 108
Chi-square=9.4 with 3 degrees of freedom. The association
between vitamin D levels normal coronaries in angiogram  was
significant (p=0.02).
Table 20: vitamin D x SVD
vitamin D
ng/ml YES NO Total P Value
>30 8 7 15 Chi square=6.99
Df=3
P=0.07
Not significant
20-30 13 21 34
10-20 10 30 40
<10 3 16 19
Total 34 74 108
Chi-square=6.99 with 3 degrees of freedom. The association
between vitamin D levels single vessel disease  on angiogram was not
significant (p=0.07).
45
Table 21: vitamin D x DVD
vitamin D
ng/ml YES NO Total P Value
>30 2 13 15 Chi
square=4.77
Df=3
P=0.19
Not significant
20-30 10 24 34
10-20 13 27 40
<10 2 17 19
Total 27 81 108
Chi-square=4.77 with 3 degrees of freedom. The association
between vitamin D levels and double vessel disease on angiogram  was
not significant (p=0.19).
Table 22: vitamin D x TVD
vitamin D
ng/ml YES NO Total P Value
>30 2 13 15 Chi
square=23.74
Df=3
P=0.000
significant
20-30 3 31 34
10-20 18 24 40
<10 13 6 19
Total 34 74 108
Chi-square=23.74  with 3 degrees of freedom. The association
between vitamin D levels and triple vessel disease on angiogram  was
significant (p=0.000).
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Table 23: vitamin D x Lt main
vitamin D
ng/ml YES NO Total P Value
>30 0 15 15 Chi
square=12.31
Df=3
P=0.01
significant
20-30 1 33 34
10-20 5 35 40
<10 6 13 19
Total 12 96 108
Chi-square=12.31  with 3 degrees of freedom. The association
between vitamin D levels left main involvement in angiogram  was
significant (p=0.01).
Table 24: vitamin D x 100% cut off
vitamin D
ng/ml YES NO Total P Value
>30 1 14 15 Chi
square=18.19
Df=3
P=0.000
significant
20-30 2 32 34
10-20 10 30 40
<10 10 9 19
Total 23 85 108
Chi-square=18.19  with 3 degrees of freedom. The association
between vitamin D levels 100% cut off in angiogram  was significant
(p=0.000).
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Table 25: vitamin D x gensini score
vitamin D
ng/ml Gensini score P Value
>30 21.25 ± 20.06 F=8.64
Df=(3,91)
P=0.000
significant
20-30 25.42 ± 23.97
10-20 42.50 ± 25.42
<10 62.00 ± 35.83
Total 38.84 ± 29.85
The association between vitamin D levels and Gensini score  was
significant (p=0.000).
Table 26: vitamin D x eGFR
vitamin
D ng/ml
eGFR>60ml/min eGFR<60ml/min Total P Value
>30 15 0 15 Chi
square=3.46
Df=3
P=0.33
Not
significant
20-30 34 0 34
10-20 38 2 40
<10 19 0 19
Total 106 2 108
Chi-square=3.46  with 3 degrees of freedom. The association
between vitamin D levels and eGFR  was  not significant (p=0.33).
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Table 27: vitamin D x ABI
vitamin
D ng/ml ABI>1
ABI
0.9-1 ABI<1 Total P Value
>30 8 7 0 15 Chi
square=6.51
Df=6
P=0.37
Not
Significant
20-30 8 24 2 34
10-20 10 28 2 40
<10 5 12 2 19
Total 31 71 6 108
Chi-square=6.51  with 6 degrees of freedom. The association
between vitamin D levels and ABI  was  not significant (p=0.37).
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DISCUSSION
This study was conducted to assess if  vitamin D levels correlate
with the atherosclerotic burden, number of coronary arteries involved and
the angiographic severity of lesions as calculated by the Gensini score in
both ACS and chronic stable angina patients. The association between
vitamin D levels and the in hospital course and complications of Acute
Coronary  Syndrome  patients  was  assessed.  In  all  patients  the  relation
between vitamin D levels and clinical and echocardiographic parameters
were assessed.
Vitamin D levels on comparison with clinical characteristics
Gender vs vitamin D levels
? In our study population of 108 patients, 83% were males
17% were females. This reflects the increased prevalence of
CAD in males
? The p value was 0.8 and no association was seen between sex
of the patient and vitamin D levels.
? 13% of males and 16 % of females had an adequate vitamin
D level >30ng/ml.
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Age Group Vs vitamin D levels
? The mean age  of the males in our study was 52.09 ± 10.29
and the females was 54.22 ±  9.42.
? The patients were divided into three groups of <40 years,40-
60 years and >60 years .The majority of our patients were
>40 years (86%) reflecting the age related risk of
atherosclerosis. The mean vitamin D levels did not vary
significantly among the three groups but was consistently
insufficient in all the age groups. The mean vitamin D levels
for the three groups were 20.79±7.98, 18.68±8.70,
18.81±8.06 respectively.
? The p value was 0.91 and there was no association between
vitamin D levels  and age groups .  Vitamin D  was deficient
across all age groups.
vitamin D levels in the entire study population
? The mean vitamin D level in the entire study population was
insufficient  (19.00±8.42).
? Only 13% of the study population irrespective of the age and
sex had an adequate vitamin D level of >30ng/ml.
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? Rest of the study population (87%) were vitamin D deficient
to varying degrees
o 17.5% were severely deficient (<10ng/ml). 31% had
hypovitaminosis (20-30ng/ml) and 37% had
insufficient vitamin D levels (10-20ng/ml)
? This reflects the high degree to which the patient population
undergoing coronary angiogram is deficient in vitamin D.
vitamin D levels in ACS and CSA patients
? 65% of our study group were Acute Coronary Syndrome
(ACS) patients
? 31%  were chronic stable angina patients (CSA)
? The  association  between the vitamin D levels and the
presentation of the patient was significant(P=0.04)
? On analyzing the vitamin D level subgroups in those with
ACS patients, only 14% had adequate vitamin D levels
(>30ng/ml), another 25 % had hypovitaminosis D (20-
30ng/ml), 38 % had insufficient vitamin D levels (10-
20ng/ml) and another 22 % had <10 ng/ml.
? Of  the  total  no  of  patients  in  our  study  who  had  vitamin  D
level of <10ng/ml , a significant 84% had an ACS
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? On analyzing the vitamin D level subgroups in those with EA
patients, only 8 % had adequate vitamin D levels (>30ng/ml),
another  44 % had hypovitaminosis D (20-30ng/ml), 38  %
had insufficient vitamin D levels (10-20ng/ml) and another 8
% had <10 ng/ml.
? Hence we see that 86% of ACS patients had inadequate
vitamin D levels and that a significant 22% of ACS were in
the lowest quartile of vitamin D level(<10ng/ml) compared
to EA/chronic stable angina patients who had inadequate
vitamin D levels in 92% and that only 8% were in the lowest
quartile of vitamin D level(<10ng/ml)
Vitamin D levels vs smoking
? 41% of our study population were smokers. The mean
vitamin D levels in smokers and non-smokers were
19.61±8.46 and  18.11±8.38 respectively.
? Inadequate vitamin D levels were seen irrespective of the
smoking status and there was no statistical association
between smoking status and vitamin D levels (P=0.67)
? Of those with adequate vitamin D levels (>30ng/ml) 66%
were non-smokers and 33.3% were smokers.Only 11% of
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smokers had adequate vitamin D levels compared to 15% of
non-smokers.
   Vitamin D levels vs hypertension
? 42% of our study population were hypertensives. The mean
vitamin D level in them was 17.32±7.89  compared to
20.25±8.65 in nonhypertensives. Both had reduced vitamin D
levels in the insufficient range and the difference between
their levels was not statistically significant (P=0.24) probably
because of  the high prevalence of vitamin D deficiency in
the population undergoing angiography100.
? Of those with adequate vitamin D levels (>30ng/ml) 80%
were non hypertensives and only 20% were hypertensives.
? Only 6% of hypertensives had adequate vitamin D levels
compared with 19.3% of non hypertensives.
? the hypertensive population was less likely to have a normal
range of vitamin D level (>30ng/ml).This is consistent with
the effect of vitamin D on the vasculature76-78.
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Vitamin D levels vs Diabetes Mellitus
? of  our  total  study  population,     were  diabetics.  The  mean
vitamin  D levels  in  diabetics  and  nondiabetics  were      and
respectively. There was no statistical significance in the
vitamin D levels between the two populations (P=0.37).
? both diabetics and nondiabetics had reduced vitamin D levels
in the insufficient range.
? Of those with adequate vitamin D levels (>30ng/ml)     were
nondiabetics and    were diabetics.
 Vitamin D levels vs dyslipidemia
? of our total study population, 49% had dyslipidemia. The
mean  vitamin D levels in those with dyslipidemia and
without  dyslipidemia were 17.67±7.77    and  20.29±8.88
respectively. There was no statistical significance in the
vitamin D levels between the two populations(P=0.13).
? both with dyslipidemia and without dyslipidemia had
reduced vitamin D levels in the insufficient range.
? 11% of those with dyslipidemia had  adequate vitamin D
levels (>30ng/ml)   while 16% of those without dyslipidemia
had  adequate vitamin D levels. Of those with adequate
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vitamin D levels (>30ng/ml)  60% were without dyslipidemia
and 40%  had dyslipidemia.
? 20% of those with dyslipidemia had vitamin D levels below
10ng/ml compared to 14% in without dyslipidemia.
? Hence even though both groups had low vitamin D levels , it
is seen that those with dyslipidemia were less likely to have
adequate vitamin D levels and more likely to have vitamin D
<10 ng/ml
 vitamin D levels vs obesity
? of our total study population, 12% had obesity. The mean
vitamin D levels in obese and non obese were 15.75±9.11
and 19.45±8.27 respectively. There was no statistical
significance in the vitamin D levels between the two
populations(P=0.06).
vitamin D levels vs NYHA Classification
? 57% of effort angina patients were in  NYHA class II and 43
% were in NYHA class III. There was no statistical
significance in the vitamin D levels between the two
functional classes(P=0.27).
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? None of the patients with functional class III had adequate
vitamin D levels compared to 15% of those with functional
class II.
vitamin D levels vs Killip Classification
? 67%  of  ACS  patients  were  in  Killip  I.  There  was  no
statistical significance between the vitamin D levels and  the
Killip class (P=0.33)
? But none of the patients in Killip II & III had adequate
vitamin D(>30ng/ml) levels compared to 16% in those
presenting with Killip I. 66% of Killip IV patients had
vitamin D levels <10 ng/ml.
vitamin D levels vs Ionotropic support
? The  association  between the vitamin D levels and
ionotropic support was significant(P=0.02)
? of our total study population, 12% required ionotropic
support
? Of those with adequate vitamin D levels (>30ng/ml) 93%
did not require any ionotropic support.
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? On analyzing the vitamin D level subgroups in those
requiring ionotropic support, only 7% had adequate vitamin
D levels (>30ng/ml), another 7% had hypovitaminosis D (20-
30ng/ml), 42% had insufficient vitamin D levels (10-
20ng/ml) and another 42% had <10 ng/ml.
? Of the total no of patients with <10ng/ml , 31% required
ionotropic support compared to 15% in those with 10-20
ng/ml and only 2% of those with 20-30 ng /ml required
ionotropic support.
? Hence we see that those with lower vitamin D levels were
more likely to require ionotropic support.This is probably
due to the greater severity of atherosclerosis lesions and
larger infarcts.
vitamin D levels vs Death
? 3% of our total study population died.
? The  association  between the vitamin D levels and mortality
was significant(P=0.01)
? On analyzing the vitamin D level subgroups in those who
died, 75% had a vitamin D level of less than 20 ng/ml. Of
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those with vitamin D levels between 10-20ng/ml, 2 % died
while 15% of those with< 10 ng/ml died.
? Hence we see that mortality was directly related to lower
vitamin D levels and significantly higher in those with the
lowest levels (<10ng/ml)
vitamin D levels vs Re MI
? 5% of our study population experienced re infarction
? The   association   between  the  vitamin  D  levels  and  re
infarction was significant(P=0.01)
? None of those who had re infarction had adequate vitamin D
levels (>30ng/ml).66% of those who developed re infarction
had vitamin D levels of <10ng/ml. Of those with vitamin D
levels of <10ng/ml , 21% developed reinfarction, while only
2% of those with levels between 10-20ng/ml and 2% in those
with 20-30ng/ml developed  re infarction.
? Hence we see that reinfarction is directly related to lower
vitamin D levels and those with the lowest vitamin D levels
had the most reinfarction.
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vitamin D levels vs arrythmias
? 25% of our study population developed arrhythmias.
? The  association  between the vitamin D levels and
arrythmias was significant(P=0.000)
? Of those with adequate vitamin D levels (>30ng/ml), only
6% developed arrhythmias, while in those with <10 ng/ml ,
63% developed arrhythmias.
? Of the total no of patients who developed arrhythmias, 3%
had a vitamin D level of >30 ng/ml, 11% had vitamin D level
of 20-30 ng/ml and 40% had a  vitamin D level of 10-20
ng/ml and 44 % had a vitamin D level of <10 ng/ml
? While only 6% of those with vitamin D level of >30ng/ml
developed arrhythmias,8% of those with vitamin D level of
20-30 ng/ml and 27% of those with vitamin D level of 10-20
ng/ml and 63% of those with vitamin D level of <10 ng/ml
developed arrhythmias.
? From this data we see that the incidence of arrhythmias rises
with falling vitamin D levels and is highest in those with
lowest vitamin D levels.
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vitamin D levels vs Left Ventricular Dysfunction
? 64% of our study population had LV dysfunction.
? The association between the vitamin D levels and LV
dysfunction was not significant.(p=0.21) . this could be due
to the fact that many of our patients were effort angina
patients who would not have sustained myocardial damage in
the absence of MI to produce the LV dysfunction
vitamin D levels vs MR
? Our study did not show any association between vitamin D
levels and MR (p=0.12). this could be due to other
confounding factors such as age, high prevalence of
physiological MR, and the frequency to which MI patients
especially inferior wall MI patients have  MR, irrespective of
angiographic severity or vitamin D status.
vitamin D levels vs aortic sclerosis
? Our study did not show any association between vitamin D
levels and the presence of aortic sclerosis. (P=0.18)
? This could be due to other confounding factors such as age
which commonly is associated with aortic sclerosis.
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vitamin D levels vs Diastolic Dysfunction
? 87% of our study population had diastolic dysfunction of
varying grades.
? The  association  between the vitamin D levels and diastolic
dysfunction was significant(P=0.000)
? This could reflect the fact that lower vitamin D levels cause
greater degrees of hypertrophy and stiffening of LV walls
reducing  their  compliance  as  vitamin  D  has  been  shown  to
regulate myocardial hypertrophy81.
vitamin D levels vs normal coronaries
? 12% of  our subjects had  normal coronaries in the
angiogram
? The  association  between the vitamin D levels and normal
coronaries was significant(P=0.02)
? the average vitamin D levels in those with normal coronaries
was  24.2 ng/ml. This is significantly higher than in that of
the entire study population but still in the hypovitaminosis
range.
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? Of those with normal coronaries only 15% had a vitamin D
value of less than 20ng/ml.61% had vitamin D levels in the
hypovitaminosis range (20-30ng/ml).
? Hence we see that patients with normal coronaries tended to
have a higher mean vitamin D level though still in the below
adequate levels.
 Vitamin D levels vs Single vessel disease
? 31% of our subjects had single vessel disease.
? The association  between the vitamin D levels and SVD was
not significant. (P=0.07)
? The average vitamin D levelsin SVD patients was 22.6
ng/ml.
? On analyzing the vitamin D level subgroups in SVD patients,
23% had adequate vitamin D (>30ng/ml), 38% had vitamin
D levels in the hypovitaminosis range (20-30ng/ml) and 29%
had vitamin D levels in the insufficient range (10-20ng/ml)
and only 8% had <10ng/ml.  We see that a patient with SVD
was less likely to have a vitamin D level of <10 ng/ml even
though statistical significance was not reached.
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vitamin D levels vs double vessel disease
? 25% of our study population had  DVD on angiograms.
? The  association  between the vitamin D levels and DVD was
not significant. (P=0.19)
? The average vitamin D levels in DVD patients was
18.3ng/ml. Though statistical significance was not reached
the  vitamin  D  levels  in  DVD  patients  was  lower  than  the
mean levels in SVD and those with normal coronaries,
showing a gradation that lower mean vitamin D levels are
encountered in patients with more number of coronaries
involved.
vitamin D levels vs triple vessel disease
? 31% of our subjects had TVD on angiograms.
? The  association  between the vitamin D levels and TVD was
significant(P=0.000)
? The average vitamin D levels in TVD patients was 13.8ng/ml
, significantly lower than that seen in the entire study
subjects.
? On analyzing the vitamin D level subgroups in TVD patients,
only 5% had adequate vitamin D (>30ng/ml), 8% had
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vitamin D levels in the hypovitaminosis range (20-30ng/ml)
and 52% had vitamin D levels in the insufficient range (10-
20ng/ml) and 38% had <10ng/ml. Almost 90% of those with
TVD had vitamin D levels <20ng/ml
? Of the total subjects who had a vitamin D level of <10 ng/ml,
68% had a triple vessel disease.
 vitamin D levels vs Lt main involvement
? 11% of our subjects had lt main art involved .
? The  association  between the vitamin D levels and Lt main
inv was significant(P=0.01)
? average vitamin D levels in lt main patients was 11.9ng/ml ,
? None of those with left main inv had adequate vitamin D
levels (>30ng/ml), 8% had vitamin D levels in the
hypovitaminosis range (20-30ng/ml) and  41%  had vitamin
D levels in the insufficient range (10-20ng/ml) and  50%  had
<10ng/ml.
? Of the total subjects who had a vitamin D level of <10 ng/ml,
31% had a lt main inv with or without involvement of other
arteries.
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? It is evident that lt main inv is more common as vitamin D
levels falls and is most common in those with the lowest
levels. The average vitamin D level was significantly lower than
in other arterial involvement.
 Vitamin D levels vs 100% cutoff
? 21%  of  our  subjects  had  100%  cut  of  f  in  coronary
angiograms.
? The  association  between the vitamin D levels and 100% cut
off was significant(P=0.000)
? of those with 100% cutoff , only 4%  had adequate vitamin D
levels (>30ng/ml), 8% had vitamin D levels in the
hypovitaminosis range (20-30ng/ml) and  43%  had vitamin
D levels in the insufficient range (10-20ng/ml) and  43%  had
<10ng/ml.
? Of the total subjects who had a vitamin D level of <10 ng/ml,
52% had a 100% cutoff.
? Hence we see that as vitamin D levels fall, the incidence of
100% cut off increases and below 20ng/ml the incidence is
extremely significant.
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 Vitamin D levels vs Gensini score
? The association between vitamin D levels and Gensini score
was  significant (p=0.000)
? The mean Gensini score for the entire study population was
38.84 ± 29.85.
? Of those with adequate vitamin D levels (>30ng/ml), the
mean Gensini score was 21.25 ± 20.06, in vitamin D levels in
the hypovitaminosis range (20-30ng/ml) the mean Gensini
score was 25.42 ± 23.97 and in the insufficient range (10-
20ng/ml) the mean Gensini score was 42.50 ± 25.42, in those
with <10ng/ml the mean Gensini score was 62.00 ± 35.83.
? It is seen that as vitamin D levels fall in the population there
is a graded increase in the Gensini score with the highest
Gensini scores seen in the lowest vitamin D levels.
 vitamin D levels vs ABI
? The association between vitamin D levels and ABI  was  not
significant (p=0.37)
 vitamin D levels vs eGFR
? The association between vitamin D levels and eGFR was  not
significant (p=0.33)
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STUDY LIMITATIONS
The study was conducted in a single center.
The sample size of the study group was small. Both these factors
could have introduced a selection bias.
The inclusion criteria was patients undergoing coronary
angiogram, the vitamin D levels in those who do not undergo angiograms
were not tested. Hence these findings cannot be extrapolated to the
general population.
The long term event rates in these patients was not assessed as
there was no long term followup.
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CONCLUSION
This study included 108 patients who underwent coronary
angiogram for various indications such as acute coronary syndromes,
effort angina/chronic stable angina and for other diagnostic indications.
The mean age of our population was 52.41
The prevalence of  vitamin D deficiency (<30ng/ml) in the entire
study population was 86%.
The mean vitamin D level in the entire study population was
insufficient  (19.00±8.42) ng/ml.
This is similar to other angiographic studies conducted on Indian
patients 98,99,100. The prevalence of vitamin D deficiency in patients
undergoing angiogram in the study by Sanjeev Kumar Syal et al100 was
80%. Hence the high prevalence of  inadequate vitamin D in the patient
population undergoing coronary angiogram was reinforced in our study
raising the possibility of vitamin D supplementation in this high risk
group.
The prevalence of  vitamin D deficiency (<30ng/ml) in the ACS
subgroup was 86% and in the EA group was 92%.
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There was a graded relationship between lower quartiles of vitamin
D levels and the proportion of patients having ACS .
Of the study group  with the lowest quartile of vitamin D
levels(<10ng/ml) the indication for angiogram was ACS in 84%
suggesting that  this subgroup has a significantly high risk for developing
an acute coronary syndrome.
There was no association between the vitamin D levels and many
demographic factors such as age, sex, smoking, diabetes, hypertension
and obesity. The lack of association is probably due to the invariably high
prevalence of vitamin D deficiency in this population irrespective of the
demographic factors.
There was an association between vitamin D levels and hard
clinical endpoints and in hospital events such as reinfarction, death,
ionotropic support, arrhythmias, presence of diastolic dysfunction and the
presentation of the patients such as ACS or chronic stable angina /EA,
and the presence of  normal coronaries, triple vessel disease, lt main
involvement and 100% cutoff in the coronary angiogram. The p value
was significant in all these parameters, thereby suggesting that lower
vitamin D levels significantly affect the extent of  atherosclerotic burden.
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Angiographically severe CAD as manifested by TVD, Lt main
involvement and 100% cutoff was significantly associated with lower
vitamin D  levels in a graded manner and most evident in those with the
lowest quartile of vitamin D levels(<10ng/ml) thereby putting these
patients at high risk of mortality and the need for CABG.
The Gensini score is a well validated measure of assessing the
severity of angiographic lesions116. The mean Gensini score for those
with adequate vitamin D levels was 21.25 . This score increased
progressively with lower vitamin D levels and  in the lowest quartile of
vitamin D (<10ng/ml) the mean Gensini score was 62.00 .
The association between vitamin D levels and the Gensini score
was significant showing that lower vitamin D levels had a higher Gensini
score and hence  greater severity of  atherosclerotic lesions.
In conclusion it was shown that vitamin D deficiency was highly
prevalent in the population subgroup undergoing angiogram and those
with lower vitamin D levels were more likely to develop an Acute
Coronary Syndrome and more likely to have reinfarction, death, require
ionotropic support and arrhythmias and more likely to have severe extent
of atherosclerosis such as triple vessel disease and left main involvement
and 100% cutoff with higher Gensini scores.
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Thus the possibility that vitamin D status can be added to the
classical risk factor profiles and vitamin D supplementation could be used
as a new mode of risk factor modification in this high risk population is
an intriguing prospect.
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1 INTRODUCTION Coronary artery disease (CAD),is a leading cause of mortality and morbidity
world wide and has reached epidemic proportions. Ischemic heart disease causes 9.4% of total
deaths (2.5 million) in less developed countries and 16.3% (1.3 million) of all deaths in well developed
countries1. The WHO has estimated that in the year 2002 alone, 12.6% of deaths all over the world
were due to coronary artery disease2. The proportion of these diseases of aging is expected to
increase as the world population gets older. The Indian scenario is similar. Studies have shown that
cardiovascular diseases cause about 40% of deaths in the urban centers and 30% of deaths in rural
centers in our...
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PROFORMA
Name: Age: Sex:
Occupation: DOA:
Address: IP NO:
CD NO:
Diagnosis:
Risk Factors:
Male Gender: Diabetes:
Smoker: Dyslipidemia
Hypertension: Family History of CAD:
In Hospital Therapy: Thrombolysis:
Inotropic Therapy:
On Examination:
HT: WT: BMI: BSA:
PR: BP:
CVS: RS:
ECG:
Killip Class On Admission:
NYHA class for CSA patients:
Investigations:
Complete Blood Count:
Urea: Creatinine: eGFR :
Electrolytes: Lipids: ABI:
CPK/MB:
VITAMIN D LEVELS:
ECHO:
LVEF, %:
LVIDD, mm: LVIDS, mm:
Diastolic Function:
MR : PHT : Aortic sclerosis :
In Hospital Events:
Death: Re-MI:
Arrhythmias:
LV Dysfunction: Mechanical Complication: VSR /
MR
Coronary angiogram:
Gensini score :
CONSENT FORM
I agree to participate in the study titled - “PREVALENCE OF VITAMIN
D DEFICIENCY IN CAD PATIENTS (ACS AND STABLE ANGINA)
AND CORRELATION WITH ANGIOGRAPHIC SEVERITY”.
I confirm that I have been told about this study in my mother tongue and
have had the opportunity to ask question.
 I understand that my participation is voluntary and I may refuse to
participate at any time without giving any reason and without affecting
my benefits.
I  agree  not  to  restrict  the  use  of  any  data  or  results  that  arise  from  the
study.
I agree to undergo the necessary investigation which is part of the study.
Name of the participant:
           Signature / thumb impression
                   Investigator

S.NO NAME AGE SEX DIABETES HYPERTENSIONSMOKING DYSLIPIDEMIAHEIGHT (cm) WEIGHT(kg) BMI kg/m2DIAGNOSIS NYHA KILLIP INOTROPIC USETHROMBOLYSISARRYTHMIASEF % aortic sclerosisPHT MR DIASTOLIC DYSFUNCTION gradeVIT D ng/mleGFR ml/hrABI normal coronariesSVD DVD TVD 100% cut offLT MAIN Gensini scoreRE MI DEATH
1 rahib khan 62 m - - - + 182 91 27.5 IMMI+PWMI+RVMI - 1 - + - 45 + + mild 1 34 108 1 - - - + - - 16 - -
2 abdul khader 60 m - - + + 160 60 23.4 IWMI+RVMI - 1 - + - 45 + - mild 1 18.8 55.56 1 - - - + + - 61 - -
3 krishnakumari 52 f - + - - 154 69 29.1 ASMI-2008/EA 2 - - - - 60 - - mild 2 8.8 140 1 - + - - - - 3 - -
4 ahamed sharif 50 m - + + + 170 70 24.2 EXT AWMI/EA 3 1 - + RBBB+LAFB 32 - - mild 2 9.8 145 0.98 - - - + + - 96 - -
5 tamil malai 41 m - - + + 164 59 23 AWMI 2009/EA 3 - - - - 57 - - - 3 21 100 1.03 - - + - + - 108 - -
6 sarojini 65 f + - - + 148 61 27.8 NSTEMI/EA 3 - - - - 64 + - mild 1 18.4 99 1.01 - - - + - + 54 - -
7 chandrababu 47 m - + + + 159 57 22.5 EA 3 - - - - 70 + - mild 1 11.9 81 1.03 - - - + + - 68 - -
8 ashok 48 m - + + - 170 75 26 IWMI+PWMI - 1 - - - 40 - - - 26 95 1.1 + - - - - - - - -
9 rupavathy 53 f - + - - 147 59 27 EA 3 - - - - 64 mild 1 12.7 89 1 - - + - + - 43 - -
10 anbalagan 55 m + + + + 165 64 23.5 IWMI+PWMI - 2 + + CHB 45 + mild mild 3 15.8 75 1.1 - + - - - - 2 - -
11 panneer selvam 70 m + - + + 161 70 27 Ext AWMI 2 + + - 40 + - - 2 18.1 88 0.9 - + - - - - 24 - -
12 govindaraj 56 m - - - + 172 71 24 AWMI - 3 + - - 42 + mild - 2 8.57 103 0.99 - - - + + - 58 - -
13 rajendran 52 m + - + - 166 65 23.6 IWMI+RVMI - 1 - - - 45 - - - 2 8.49 88.27 1.02 - - - + - + 41 - -
14 kennedy 50 m - - + + 160 60 23.4 IWMI+PWMI+RVMI - 2 - + 1st deg AV block 52 - - mild 1 22.2 83 1.02 - + - - - - 25 - -
15 chinnaiah 68 m + + - - 166 75 27.2 EA 3 - - - - 66 + - - 1 28 125 1 - - - + - - 52 - -
16 suresh 43 m - - + + 165 72 26.4 AWMI - 3 + + - 40 - - mild 1 25 121 1 + - - - - - - - -
17 dawood basha 52 m - - - - 163 66 24.8 IWMI+PWMI+LWMI - 1 - + - 59 - - - - 14.8 73 1 - - - + + - 59 - -
18 ashok 42 m - + + + 164 64 23.8 IWMI+PWMI - 1 - - 1st deg AV block 40 - - - 1 15 67 0.9 + - - - - - - - -
19 manavalan 54 m - - - - 165 65 23.9 IWMI+PWMI+RVMI - 1 - + 2:1 AV block 45 + - mild 1 12.2 110 1 - + - - - - 8 - -
20 kathirvel 43 m - + + + 159 78 30.9 UA - - - - - 60 - - - - 12.9 150 1 - - - + - - 70 - -
21 kanagavalli 54 f + + - - 156 70 28.8 NSTEMI - - - - RBBB 45 + - mild 1 6.51 92 0.98 - - - + + + 164 + -
22 malathy 48 f - - - - 146 53 24.9 HLMI - 1 - + - 47 + - mild 3 8.01 96 1.12 - + - - - - 28 - -
23 kennedy 43 m - - + - 175 69 22.5 IWMI+PWMI+RVMI - 1 - + - 60 + - mild - 30 80 1.1 - - + - - - 5 - -
24 mohamad rafiq 40 m - - + + 169 101 35 IWMI+PWMI - 1 - + 1st deg AV block 45 - - mild 1 8.9 154 0.97 + - - - - - - - -
25 rajendran 60 m - - - + 157 66 26.8 IWMI - 1 + CHB 52 + - mild 1 8.8 73 0.89 - - - + + - 63 - -
26 lathif 50 m - - + - 157 52 21.1 IWMI - 1 - + 1st deg AV block 60 + - - 1 13.7 72 0.98 - + - - - - 10 - -
27 jahangir basha 62 m - - + + 162 76 29 EA 2 - - - - 49 + - mild 1 12.3 64 0.89 - + - - + - 80 - -
28 govindaraj 57 m - - - - 164 63 23.4 IWMI - 1 - + - 57 - - - - 22.8 98 1 - - - + - - 59 + -
29 abdul rahman 35 m - - + - 160 60 23.4 AWMI - 1 - + - 45 - - - 1 13 96 1 - - + - - - 16 - -
30 selvam 47 m + + + + 172 66 22.3 EA 3 - - - - 56 - + mild 1 12.7 66 1.12 - - - + - - 48 - -
31 shabana begum 37 f - - - + 150 65 28.9 EA 2 - - - - 60 - - - - 22 76 1.1 + - - - - - - - -
32 jeeva 49 m + - + - 166 70 25.4 old ASMI/recurrent UA - - - - - 48 - - mild 1 22.1 61 1 - + - - - - 20 - -
33 sultana begum 52 f + + - + 149 60 27 NSTEMI - - - - - 47 - + mild 1 14 65 1.01 - - + - - - 57 - -
34 chandra 63 f + - - + 152 53 22.9 EA 2 - - - - 61 + + moderate 1 23.1 60 1 - + - - - - 28 - -
35 pari 50 m - + + - 170 68 23.5 EA 3 - - - - 57 + + mild 3 11 59 1 - - - + - - 38 - -
36 arokiathavamani 43 m + - + - 171 78 24.6 old AWMI/EA 2 - - - - 44 - - - 2 28 78 1 - - + - - - 19 - -
37 Karuppanan 64 m + + - - 161 76 29.3 old IWMI/EA 3 - - - - 49 + + mild 3 10.1 64 1 - - - + - - 36 - -
38 saravanan 32 m - - + - 168 71 25.2 AWMI - 1 - + - 46 - - - 1 21.2 87 1.03 - + - - - - 20 - -
39 srinivasan 36 m - - + + 173 78 26.1 AWMI - 1 - + - 50 - - - 1 18 98 1.2 - + - - - - 12 - -
40 antony dasan 55 m + - + + 175 82 26.8 EA 2 - - -  LBBB 57 + - - 2 8 77 1.02 - - - + + - 94 - -
41 meenakshi 52 f + + - + 156 70 28.8 EA 2 - - - - 60 - + - 2 28 95 1 - - + - - - 14 - -
42 rajasekhar 46 m - + + - 178 92 29 AWMI - 3 + + - 40 - + mild 3 12.1 87 1 - - - + - - 16 - -
43 sundar 52 m + + - - 174 81 26.8 IWMI+PWMI+RVMI - 1 - + 1 deg AV block 45 - - mild 1 10.2 80 1 - - - + - - 26 - -
44 john basha 53 m - - + - 165 82 30.1 NSTEMI - - - - - 51 - - - 1 34 100 1.1 - + - - - - 2 - -
45 venkateswarulu 64 m + - - + 173 88 29.4 IWMI+PWMI - 1 - + 1 deg AV block 50 + + mild 1 9.7 86 0.9 - - - + - - 34 - -
46 alagammal 52 f + - - - 150 60 26.7 EA 3 - - - - 60 - - - 1 13 91 1 - - - + - - 44 - -
47 nagarajan 36 m - + + - 171 80 27.4 Ext AWMI - 1 - + - 50 - - - 1 29.1 101 1 - + - - - - 2 - -
48 narasimman 67 m + + - + 175 79 25.8 EA/AS/AR 2 - - - - 52 + + mild 1 11 63 0.9 - - - + - - 50 - -
49 abdul latif 60 m + + - + 160 75 29.3 IWMI - 1 - - CHB 50 + - mild 1 8.8 76 1 - - - + - + 77 + -
50 ayyadurai 60 m - + - + 177 82 26.2 renal donor - - - - - 66 - - - - 32 98 1.02 + - - - - - - - -
51 durai 42 m + - + - 174 88 29.1 Ext AWMI - 1 - + - 53 - - - 1 35 121 1.03 + - - - - - - - -
52 janarthanan 62 m + - + - 163 75 28.2 EA 2 - - - - 58 + - mild 1 30 98 1 - - - + - - 65 - -
53 periyasamy 65 m - + + + 169 84 29.4 old IWMI /EA - - - - - 54 + + mild 1 25 113 1 + - - - - - - - -
54 babulal 63 m + - - + 170 92 31.8 AWMI - 3 + + - 42 + + mild 3 19 94 1.01 - - - + - - 50 - -
55 settu 48 m - - + + 181 107 32.7 IWMI/PIA 2 - - - - 56 - - - 1 13 88 1.11 - - + - - - 11 - -
56 banumathi 57 f + + - - 157 70 28.4 EA 2 - - - - 63 - - - - 22 100 1 + - - - - - - - -
57 harikrishnan 36 m - - + - 172 84 28.4 AWMI - 1 - + - 50 - - - 1 28 94 1 - + - - - - 13 - -
58 francis 70 m + + - - 177 80 25.5 IWMI+PWMI - 2 + + CHB 45 + + mild 1 9 69 1.13 - - - + + - 55 - -
59 gowtham jothi 41 m - - + - 184 97 28.7 IWMI+LWMI - 1 - + - 49 - - mild 1 8.7 62 0.94 - - - + + - 72 - -
60 kanagamani 58 m - + + + 169 82 28.7 EA 2 - - - - 58 - - - - 34 102 1 + - - - - - - - -
61 prabakaran 52 m - - + - 170 73 25.3 IWMI - 1 - + - 53 - - mild 1 26 82 1.12 + - - - - - - - -
62 charles 28 m - - + - 185 93 27.2 AWMI - 1 - - - 50 - - - 1 24 70 1 + - - - - - - - -
63 lakshmanasamy 75 m + + - + 162 78 27.6 IWMI - 3 + + mobitz 2 48 + + mild 1 15.3 68 0.89 - - + - - - 52 - -
64 shajahan 60 m + - + + 178 92 29 EA/post CABG 3 - - - - 42 + + moderate 1 17.4 76 1 - + - - - - 46 - -
65 srinivasan 56 m + + - - 167 88 31.6 old IWMI/NSTEMI - - - - - 49 + - - 1 16.7 65 1 - - - + - - 30.5 - -
66 salim nisha 68 f + + - - 155 67 27.9 R/O CAD - - - - CHB 54 + _ mild 1 20.1 79 0.89 + - - - - - - - -
67 selvaraj 68 m - + + + 173 79 26.4 EA 3 - - - - 50 - - - 1 9.6 61 0.9 - - - + + - 72 - -
68 nagoor meeran 60 m + - - - 160 76 29.7 EA 3 - - - - 58 - - mild 1 23 84 1 - - - + + - 78 - -
69 abdul ajeez 55 m + + - + 174 87 28.7 AWMI - 4 + + CHB 40 - + mild 1 9.7 60 1 - - - + + + 66 + +
70 babu 56 m - + + + 167 82 29.4 NSTEMI - - - - - 51 - - - 1 12.3 82 0.99 - - + - + - 96 - -
71 chandra 60 m + - - - 161 70 27 EA/AS 2 - - - - 57 + + mild 3 26.8 85 1.11 - + - - - - 5 - -
72 dhanasekharan 62 m - + + + 178 89 27.8 ASMI - 2 - + - 48 - - - 1 21.8 96 1 - - + - - - 29 - -
73 janagiraman 52 m - - + + 181 89 27.2 AWMI - 1 - - - 53 - - - - 34 110 1.2 - + - - - - 32 - -
74 kannaiyan 40 m + - + + 166 90 32..7 AWMI - 3 + - mobitz 2 38 - - - 2 8.9 60 0.97 - - - + - + 30 - +
75 kumar 43 m - + - - 150 58 26 renal donor - - - - - 61 - - - - 29.2 103 0.97 - + - - - - 4 - -
76 moinudeen 59 m + + - + 176 98 31.6 old AWMI/post CABG 2 - - - - 44 - + moderate 3 11 79 0.99 - - - + + + 84 - -
77 nagappan 48 m - - + + 160 78 30.5 NSTEMI AW - - - - - 50 - - mild 1 11.2 65 1.05 - - + - + + 94 - -
78 poosalingam 50 m - + + - 167 73 26.2 ASMI - 1 - + - 47 - - - 1 25 98 1 - - + - - - 20 - -
79 udhayakumar 54 m + - - + 170 89 27.8 AS/AR EA 2 - - - - 56 + + mild 1 23.1 73 1 - - + - - - 24 - -
80 chandrasekharan 48 m - + + + 169 78 27.3 AWMI - 1 - + - 53 - - - 1 21 71 1.05 - - + - - - 12 - -
81 mohan 52 m - - + - 167 98 35.1 IWMI - 1 - + - 55 - - mild 1 10.4 89 0.91 - + - - - - 20 - -
82 mary 40 f + - - - 158 70 28 EA 2 - - - - 60 - - - - 32 110 1.07 - + - - - - 10 - -
83 raja 40 m + + + + 166 75 27.2 UA - - - - - 52 - - - 1 12.3 88 1 - - + - - - 32 - -
84 uthirapathy 37 m + - + - 170 70 24.2 UA - - - - - 58 - - - 1 35 100 1.21 - + - - - - 3 - -
85 krishnaveni 72 f - - - - 150 59 26.2 old IWMI/EA 2 - - - - 49 + - mild 1 29.1 96 0.88 - + - - - - 8 - -
86 seenu 42 m - + + - 164 94 34.9 AWMI - 3 + + lbbb 40 - - - 1 8 63 1.04 - + - - + - 80 - -
87 selvarani 45 f + - - + 162 66 24 AWMI - 1 - - - 44 - - - 1 33 84 1 - - + - - - 38 - -
88 subramaniyam 58 m - - + - 178 84 25.6 EA 2 - - - - 62 - - mild 1 11.7 88 0.99 - - + - - - 13 - -
89 subramani 61 m - + + - 182 89 26.9 UA - - - - - 58 + - - 1 26 98 1 - + - - - - 20 - -
90 arul 26 m - - + - 185 90 26.3 ext AWMI - 2 - - - 46 - - - 1 20.1 94 1 - + - - - - 20 - -
91 azim 52 m + + - + 168 88 31.2 IWMI+PWMI - 1 - + 1st deg AV block 49 - + moderate 1 14.8 71 1 - - - + + + 56 + -
92 davidraj 53 m - - + - 177 84 26.8 renal donor - - - - - 60 - - - - 33 109 1.03 - + - - - - 10 - -
93 laila 53 f - + - + 158 70 28 IWMI+PWMI - 1 - + - 52 - - mild 1 27 89 1 - + - - - - 13 - -
94 adhikesavan 63 m + - + - 170 85 29.4 AWMI - 3 + + RBBB 44 + - mild 3 15.2 63 0.9 - - + - - - 48 - -
95 augustine 38 m - - + + 185 90 26.3 ext AWMI - 2 - + - 42 - - - 1 18 96 1 - - + - - - 34 - -
96 raji 48 m - - + - 169 78 27.3 AWMI - 1 - + - 47 - - - 1 33 101 0.99 - + - - - - 10 - -
97 balan 58 m - + + - 171 80 27.4 EA 2 - - - - 58 - - mild 1 24.6 88 1 - - + - - - 20 - -
98 elango 60 m + + - + 173 89 29.7 AWMI - 4 + + RBBB 38 + - mild 3 8.9 60 0.87 - - + - - + 60 + +
99 gracy 48 f - + - + 157 70 28.4 AWMI - 1 - + - 49 - - - 1 18.7 100 1 - + - - - - 20 - -
100 bose 60 m - - + - 178 90 28.4 AWMI - 1 - + - 50 + - mild 1 23.9 98 1 - - + - - - 8 - -
101 damodharan 65 m + - - + 180 93 28.7 EA 3 - - - lbbb 43 + + mild 2 12.7 77 1 - - + - - + 54 - -
102 natarajan 46 m - - + - 160 80 31.2 UA - - - - - 50 - - - 1 36 107 1 - + - - - - 16 - -
103 irudhayaraj 45 m + - + + 173 82 27.4 EA 3 - - - RBBB 57 - - - 1 23.5 94 1 - + - - - + 20 - -
104 jaganathan 68 m + - + - 180 88 27.2 UA - - - - - 58 + + moderate 1 9.7 95 0.99 - - + - - - 23 - -
105 mohideen basha 40 m - - + - 172 84 28.4 UA - - - - - 52 - - - 1 21.3 87 1 - - + - - - 20 - -
106 murugesan 63 m - - + - 180 93 28.7 IWMI - 1 - + 1st deg AV block 58 - - mild 1 11.7 103 0.97 - + - - - - 10 - -
107 padmavathy 65 f - + - + 156 68 27.9 ASMI - 4 + + RBBB+LAFB 38 + + moderate 3 32.6 97 1 - + - - + - 48 - +
108 prakash 48 m + + - - 179 91 28.4 EA 2 - - - - 61 - - - 1 15.9 98 1.2 - - + - + - 85 - -
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